Skip to content

Assessement of Hepcidin in Saliva in Human Volunteers

Detection of Hepcidin in Saliva and Its Utility as a Diagnostic Marker for Iron Deficiency

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03816813
Enrollment
90
Registered
2019-01-25
Start date
2019-02-04
Completion date
2019-02-07
Last updated
2019-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepcidin, Saliva

Brief summary

Iron deficiency with or without anemia is considered the most widespread nutritional deficiency in the world. To diagnose iron deficiency anemia (hemoglobin and ferritin measurement), a venous blood sample is necessary. Whole saliva is a potentially attractive fluid for disease biomarker discovery and diagnostic efforts, because it is readily available from most individuals, can be easily collected and the collection procedure is non-invasive. The iron storage protein ferritin is too big, to be secreted into saliva. However, the main iron regulatory protein hepcidin is a very small protein and there is some evidence for hepcidin detection in saliva. The production of serum hepcidin positively correlates with serum ferritin, thereby reflecting patient's iron status. Whether hepcidin is detectable in saliva and whether saliva hepcidin correlates with serum hepcidin with current assays, needs to be tested.

Interventions

blood and saliva sampling

Sponsors

Swiss Federal Institute of Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years

Inclusion criteria

* Normal-weight (BMI 18-24.9kg/m2) * fasting * Participants Need to have brushed their teeth at least 1 hour before the visit

Exclusion criteria

* acute, chronic illness * use of long-term medication other than contraception * medical Problems known to affect Fe homeostasis * smoking

Design outcomes

Primary

MeasureTime frameDescription
Saliva hepcidinDay 1am
Serum hepcidinDay 1am
Serum ferritinDay 1amIron Status parameter

Secondary

MeasureTime frameDescription
alpha-glycoproteinDay 1amInflammation parameter
HemoglobinDay 1am
Saliva hepcidinDay 1pmto assess variability in saliva hepcidin during the day
Transferrin receptorDay 1amIron Status parameter
c-reactive proteinDay 1amInflammation parameter

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026